Simulations Plus

Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules solely from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. The Company provides specific proprietary software products, such as GastroPlus, a physiologically-based simulation tool that predicts the absorption, pharmacokinetics, pharmacodynamics, and drug-drug interactions for compounds administered through intravenous, oral, ocular, or pulmonary routes; ADMET Predictor, an ADME-Tox property prediction, and model building application; MedChem Studio, a multi-purpose cheminformatics platform used for advanced data mining and de novo molecule design; DDDPlus, a simulation program for formulation scientists that predicts the in vitro disintegration and dissolution of solid dosage forms under different experimental conditions;  MedChem Designer, a free chemical sketching product that combines innovative molecule drawing features with fast and accurate ADMET property predictions from ADMET Predictor.

Company Growth (employees)
Lancaster, US
Size (employees)
60 (est)+6%
Simulations Plus was founded in 1996 and is headquartered in Lancaster, US

Simulations Plus Office Locations

Simulations Plus has offices in Lancaster and Buffalo
Lancaster, US (HQ)
42505 10th St W
Buffalo, US
110 1780 Wehrle Dr

Simulations Plus Data and Metrics

Simulations Plus Financial Metrics

Simulations Plus's revenue was reported to be $20 m in 2016 which is a 9% increase from the previous period.
Numbers are in $, USD

Revenue (Y, 2016)

20 m

Revenue growth (Y, 2015 - Y, 2016), %


Gross profit (Y, 2016)

15.4 m

Gross profit margin (Y, 2016), %


Net income (Y, 2016)

5 m

EBIT (Y, 2016)

7.2 m

Market capitalization (21-Jun-2017)

207.7 m

Closing share price (21-Jun-2017)


Cash (31-Aug-2016)

8 m
Simulations Plus's current market capitalization is $207.7 m.
Y, 2014Y, 2015Y, 2016


11.5 m18.3 m20 m

Revenue growth, %


Cost of goods sold

1.6 m4.3 m4.6 m

Gross profit

9.8 m14 m15.4 m

Gross profit Margin, %


Operating expense total

5.4 m8.1 m8.1 m


4.4 m5.9 m7.2 m

EBIT margin, %


Interest income

31.4 k17.9 k18 k

Pre tax profit

4.5 m

Income tax expense

(1.5 m)(1.8 m)(2.3 m)

Net Income

3 m3.8 m5 m
FY, 2013FY, 2014FY, 2015FY, 2016


8.6 m8.6 m8 m


188.2 k381.7 k410.8 k

Current Assets

11.5 m11.5 m12.9 m


95.2 k413.5 k256.4 k


4.8 m4.8 m

Total Assets

21 m27.3 m28 m

Accounts Payable

130.5 k209.4 k108.1 k

Current Liabilities

1.4 m3.6 m2.1 m

Additional Paid-in Capital

6.1 m9.7 m11.4 m

Retained Earnings

9.3 m9.8 m11.3 m

Total Equity

15.4 m19.5 m22.7 m

Financial Leverage

1.4 x1.4 x1.2 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

3 m3.8 m5 m

Accounts Receivable

1 m(1.4 m)


192.2 k

Accounts Payable

146 k(15.5 k)19.4 k(101.3 k)

Cash From Operating Activities

5.3 m7.1 m5.4 m

Purchases of PP&E

(24.5 k)(71.4 k)(39.1 k)

Cash From Investing Activities

(3.9 m)(3.1 m)(2 m)

Income Taxes Paid

692.6 k961.9 k2.9 m
Numbers are in $, USDY, 2016


350.4 k

Financial Leverage

1.2 x

Simulations Plus Market Value History

Simulations Plus Online and Social Media Presence

Simulations Plus Company Life and Culture

You may also be interested in